Myriad Women’s Health: Empowering women and their families to make critical and timely healthcare decisions January 10, 2019 Counsyl, Inc. has combined with Myriad Genetics’ Preventive Care business unit to form Myriad Women’s Health, Inc., a premier genetic screening and personal... Continue Reading
EndoPredict is the Only Test to Answer Three Critical Questions December 7, 2018 EndoPredict is the Only Test to Answer Three Critical Questions: Risk of Breast Cancer Recurrence, Benefits of Chemotherapy and Who Can Forgo Extended Endocrine... Continue Reading
Genetic Testing Helps Personalize Breast Cancer Treatment Decisions October 1, 2018 According to the American Cancer Society, 1 in 8 U.S. women will be diagnosed with breast cancer in their lifetime. In 2018, about 266,000 new cases of breast... Continue Reading
Genetic Testing Can Help Men with Prostate Cancer Receive the Right Treatment September 1, 2018 September is Prostate Cancer Awareness Month. According the American Cancer Society, more than 165,000 men will be diagnosed with prostate cancer this year, and... Continue Reading
Helping to Realize the Benefits of Personalized Medicine for Minority Populations July 2, 2018 The biomedical innovation now happening in the molecular diagnostics industry is making it possible for clinicians to answer their patients’ four most pressin... Continue Reading
GeneSight: Helping Patients with Depression May 15, 2018 Mental Health Month, Depression and GeneSight® The GeneSight® genetic test has produced exciting news for patients diagnosed with depression. A landmar... Continue Reading
Hereditary Colon Cancer March 1, 2018 In hereditary colon cancer, knowledge is power! During the month of March, Myriad Genetics is demonstrating a strong commitment to preventing hereditary col... Continue Reading
BRACAnalysis CDx Approved by FDA for Patients with HER2- Metastatic Breast Cancer January 23, 2018 The U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® for use as a companion diagnostic to identify patients with HER2- metastatic breas... Continue Reading
Winter Depression is a Serious Health Issue for Many People January 17, 2018 It is estimated that 19 million people suffer from “year round” depression. If every American with depression lived in one state it would be the country’s... Continue Reading
Andrea’s story: Cancer prevention can begin with knowing your family history October 10, 2017 Shortly after I was born, my father was diagnosed with Hodgkin’s lymphoma and he passed away when he was just 29 years old. Losing my dad when I was so youn... Continue Reading
Genetic Precision for Prostate Cancer Patients September 12, 2017 When diagnosed with prostate cancer, genetic precision can guide decisions between patients and their doctors. Click below to learn more and download this infog... Continue Reading
Myriad Partners with Project BioEYES to Improve STEM Education July 13, 2017 Myriad Genetics was proud to support Project BioEYES and help deliver STEM (science, technology, engineering, and mathematics) education to K-12 students thro... Continue Reading
Men’s Health Month and Myriad’s Prolaris Test June 12, 2017 June is Men’s Health Month and it’s important to help generate awareness on education for early detection of Men’s health issues, such as prostate cance... Continue Reading
GeneSight: Ronni’s Patient Story May 15, 2017 “I just could not get out of bed, no matter how hard I tried.” Years ago, before taking the GeneSight test, Ronni went through a very traumatic expe... Continue Reading